Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome b-245 heavy chain mRNA, commonly known as NOX2 mRNA, is the transcript of the CYBB gene located on the X chromosome (NCBI Gene ID: 1536). It encodes the gp91-phox protein, which serves as the catalytic core of the NADPH oxidase 2 complex, an enzyme primarily expressed in phagocytes that generates superoxide anions during the respiratory burst (UniProt: P04839). This process is essential for the innate immune system's ability to destroy invading pathogens. However, the dysregulation or overexpression of NOX2 mRNA is heavily implicated in the pathogenesis of various diseases characterized by oxidative stress, including atherosclerosis, hypertension, and neurodegenerative disorders like Alzheimer's disease (PubMed: 25223554). Therapeutic strategies targeting NOX2 mRNA, such as small interfering RNAs (siRNA) and antisense oligonucleotides (ASOs), are being investigated to selectively downregulate NOX2 expression and mitigate tissue damage caused by excessive reactive oxygen species (PubMed: 21653890). A significant challenge in targeting this molecule is the risk of inducing an immunocompromised state similar to Chronic Granulomatous Disease, which results from a total loss of NOX2 function (StatPearls: NBK537072).
RNA interference or antisense-mediated degradation of mRNA to inhibit translation of the NOX2 protein, thereby reducing superoxide production.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome b-245 heavy chain mRNA (NOX2 mRNA) (NOX2 mRNA).